Trials / Completed
CompletedNCT02473393
A Clinical Trial to Assess Three Different Doses of OPS-2071 in Patients With Bacterial Enteritis
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 43 (actual)
- Sponsor
- Otsuka Pharmaceutical Co., Ltd. · Industry
- Sex
- All
- Age
- 19 Years – 74 Years
- Healthy volunteers
- Not accepted
Summary
To assess safety, efficacy and pharmacokinetics of multiple dosesin patients with Bacterial Enteritis caused by Clostridium difficile infection(CDI) or Enteric infection.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | OPS-2071 tablet |
Timeline
- Start date
- 2015-08-20
- Primary completion
- 2017-03-14
- Completion
- 2017-03-14
- First posted
- 2015-06-16
- Last updated
- 2021-03-24
- Results posted
- 2021-03-24
Locations
3 sites across 3 countries: Japan, Singapore, South Korea
Source: ClinicalTrials.gov record NCT02473393. Inclusion in this directory is not an endorsement.